Unique ID issued by UMIN | UMIN000031699 |
---|---|
Receipt number | R000036204 |
Scientific Title | The effect of docosahexaenoic acid and eicosapentaenoic acid -enriched milk beverage ingestion on erythrocyte plasma membrane fatty acid levels of the elderly |
Date of disclosure of the study information | 2018/03/13 |
Last modified on | 2021/04/15 15:12:54 |
The effect of docosahexaenoic acid and eicosapentaenoic acid -enriched milk beverage ingestion on erythrocyte plasma membrane fatty acid levels of the elderly
The effect of docosahexaenoic acid and eicosapentaenoic acid -enriched milk beverage ingestion on erythrocyte plasma membrane fatty acid levels of the elderly
The effect of docosahexaenoic acid and eicosapentaenoic acid -enriched milk beverage ingestion on erythrocyte plasma membrane fatty acid levels of the elderly
The effect of docosahexaenoic acid and eicosapentaenoic acid -enriched milk beverage ingestion on erythrocyte plasma membrane fatty acid levels of the elderly
Japan |
The elderly
Adult |
Others
YES
The object is how docosahexaenoic acid and eicosapentaenoic acid -enriched milk beverage ingestion on erythrocyte plasma membrane fatty acid levels of the elderly.
Efficacy
Changes in erythrocyte membrane fatty acid composition
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
YES
Institution is not considered as adjustment factor.
No need to know
2
Prevention
Food |
Docosahexaenoic acid and eicosapentaenoic acid -enriched milk beverage
Placebo milk beverage
65 | years-old | <= |
85 | years-old | >= |
Male and Female
1) The age at consent is 65 years old or over and 85 years old or younger.
2) The cognitive function test value at the start of the test satisfies all of the following.
.total MMSE is 22 points or more
.HDS-R scores is 21 points or more
3) Agreement has been obtained from the principal concerning research participation in writing.
4) Conversation in Japanese is possible.
1) Development of dementia and osteoporosis.
2) Use a antipsychotics, dementia treatment drugs, anticoagulants and antiplatelet drugs.
3) Taking drugs containing EPA and/or DHA, and supplements that are expected to improve brain function and to reduce serum triglyceride levels.
4) Having a habit of ingesting fats and oils as they are.
5) Having allergy to milk.
150
1st name | Michio |
Middle name | |
Last name | Hashimoto |
Shimane University
Faculty of Medicine, Department of Environmental Physiology
693-8501
89-1 Enyacho, Izumo, Shimane 693-8501, Japan
0853-20-2730
michio1@med.shimane-u.ac.jp
1st name | Michio |
Middle name | |
Last name | Hashimoto |
Shimane University
Faculty of Medicine, Department of Environmental Physiology
693-8501
89-1 Enyacho, Izumo, Shimane 693-8501, Japan
0853-20-2730
michio1@med.shimane-u.ac.jp
Shimane University
FUJI OIL HOLDINGS INC.
Profit organization
Japan
Shimane University
89-1 Enyacho, Izumo, Shimane, Japan
0853-20-2730
michio1@med.shimane-u.ac.jp
NO
2018 | Year | 03 | Month | 13 | Day |
Partially published
108
Delay expected |
For patent application
Main results already published
2017 | Year | 11 | Month | 02 | Day |
2019 | Year | 02 | Month | 25 | Day |
2018 | Year | 02 | Month | 01 | Day |
2019 | Year | 02 | Month | 01 | Day |
2019 | Year | 02 | Month | 28 | Day |
2019 | Year | 03 | Month | 31 | Day |
2021 | Year | 03 | Month | 31 | Day |
2018 | Year | 03 | Month | 13 | Day |
2021 | Year | 04 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036204